Evidence map›Paper›PMID 22047141›Full record

ArticleMolecular neurodegeneration2011

Generation and characterization of transgenic mice expressing mitochondrial targeted red fluorescent protein selectively in neurons: modeling mitochondriopathy in excitotoxicity and amyotrophic lateral sclerosis.

Yi Wang, Yan Pan, Ann Price, Lee J Martin

Open access · goldAbstract read
In one paragraph

Article in Molecular neurodegeneration, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. The dynamics of the mitochondrial organelle as a potential therapeutic target.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2013
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yi WangDepartment of Pathology, Division of Neuropathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, MD 21205, USA.
Yan Pan
Ann Price
Lee J Martin
Johns Hopkins Medicine · USJohns Hopkins University · US

Funding

MECHANISMS OF NEURONAL APOPTOSIS IN VIVOR01AG016282 · NIA · JOHNS HOPKINS UNIVERSITY · PI MARTIN, LEE J · 2000 to 2009
$2.6M
MOTOR NEURON DEATH AND GLUTAMATE RECEPTORSR01NS034100 · NINDS · JOHNS HOPKINS UNIVERSITY · PI MARTIN, LEE J · 1996 to 2006
$2.1M
Skeletal Muscle Mechanisms of Disease in ALSR01NS065895 · NINDS · JOHNS HOPKINS UNIVERSITY · PI MARTIN, LEE J · 2010 to 2014
$1.7M
DNA Damage/Repair and Cell DeathR01NS052098 · NINDS · JOHNS HOPKINS UNIVERSITY · PI MARTIN, LEE J · 2005 to 2009
$1.5M
NIA NIH HHS R01-AG016282NINDS NIH HHS NS065895NINDS NIH HHS R01-NS034100NINDS NIH HHS R01-NS052098
6 · The paper itself

Abstract

backgroundMitochondria have roles or appear to have roles in the pathogenesis of several chronic age-related and acute neurological disorders, including Charcot-Marie-Tooth disease, amyotrophic lateral sclerosis, Parkinson's disease, and cerebral ischemia, and could be critical targets for development of rational mechanism-based, disease-modifying therapeutics for treating these disorders effectively. A deeper understanding of neural tissue mitochondria pathobiologies as definitive mediators of neural injury, disease, and cell death merits further study, and the development of additional tools to study neural mitochondria will help achieve this unmet need.

resultsWe created transgenic mice that express the coral (Discosoma sp.) red fluorescent protein DsRed2 specifically in mitochondria of neurons using a construct engineered with a Thy1 promoter, specific for neuron expression, to drive expression of a fusion protein of DsRed2 with a mitochondrial targeting sequence. The biochemical and histological characterization of these mice shows the expression of mitochondrial-targeted DsRed2 to be specific for mitochondria and concentrated in distinct CNS regions, including cerebral cortex, hippocampus, thalamus, brainstem, and spinal cord. Red fluorescent mitochondria were visualized in cerebral cortical and hippocampal pyramidal neurons, ventrobasal thalamic neurons, subthalamic neurons, and spinal motor neurons. For the purpose of proof of principle application, these mice were used in excitotoxicity paradigms and double transgenic mice were generated by crossing Thy1-mitoDsRed2 mice with transgenic mice expressing enhanced-GFP (eGFP) under the control of the Hlxb9 promoter that drives eGFP expression specifically in motor neurons and by crossing Thy1-mitoDsRed2 mice to amyotrophic lateral sclerosis (ALS) mice expressing human mutant superoxide dismutase-1.

conclusionsThese novel transgenic mice will be a useful tool for better understanding the biology of mitochondria in mouse and cellular models of human neurological disorders as exemplified by the mitochondrial swelling and fission seen in excitotoxicity and mouse ALS.

Indexed as

Mice, TransgenicAmyotrophic Lateral SclerosisAnimalsBrainCell LineDisease Models, AnimalHumansLuminescent AgentsLuminescent ProteinsMiceMitochondriaNeuronsRecombinant Fusion ProteinsRed Fluorescent ProteinLuminescent AgentsLuminescent ProteinsRecombinant Fusion ProteinsRed Fluorescent Protein

Identifiers

PMID22047141
PMCPMC3227596
OpenAlexW1999701501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.